BiotechTube
Home/Genervon Biopharmaceuticals/Winston Ko
WK

Winston Ko

Chief Executive Officer, Chairman of the Board

Genervon Biopharmaceuticals

Therapeutic Areas

Neurodegenerative Diseases

Genervon Biopharmaceuticals Pipeline

DrugIndicationPhase
GM6Amyotrophic Lateral Sclerosis (ALS)Phase 2

Leadership Team at Genervon Biopharmaceuticals

DK
Dorothy Ko
Leadership Team
View full Genervon Biopharmaceuticals profile